Characterizing Treatment Utilization Patterns for Trigeminal Neuralgia in the United States
Conclusions:
In the 3 years after diagnosis, patients with TN in the United States receive a variety of pharmacological treatments, including opioids, despite carbamazepine being the only approved medication. A notable proportion utilize surgeries/injections. A high proportion of pharmacologically treated patients receive multiple treatment episodes, suggesting frequent therapy switching, perhaps because of suboptimal efficacy/tolerability. Our data suggest a high burden of illness associated with TN.
Source: The Clinical Journal of Pain - Category: Anesthesiology Tags: Original Articles Source Type: research
More News: Anesthesia | Anesthesiology | Baclofen | Carbamazepine | Cymbalta | Databases & Libraries | Gabapentin | Ganglions | Lyrica | Medicare | Neurontin | Pain | Topamax | USA Health